May 06, 2021

Dr. John Sheppard, president, Virginia Eye Consultant, Norfolk, and Natalia Perekhvatova, CEO of Mitotech S.A., discussed the potential of the company’s ophthalmic formulation of its lead compound SkQ1 for the treatment of a spectrum of eye diseases in a recent article by Fierce Biotech. You can access the full article here:

Mitotech brings novel approach to treating eye disorders